The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Unicycive Therapeutics, Inc.(NASDAQ:UNCY) 
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company ...
Website: https://www.unicycive.com
Founded: 2016
Full Time Employees: 9
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Unicycive Therapeutics . Days Payable Outstanding ttm (DPO)
Unicycive Therapeutics . Op Cashflow Per Share ttm
Unicycive Therapeutics . Free Cashflow Per Share ttm
Unicycive Therapeutics . Cash Per Share ttm
Unicycive Therapeutics . P/S ratio ttm
Unicycive Therapeutics . (GAAP) P/E ratio ttm
Unicycive Therapeutics . P/B ratio ttm
No extra charts and metrics for this ticker.